A Study of the Novel Drug Dimebon in Patients With Huntington's Disease

NCT00497159 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington's Disease

Interventions

OTHER: Placebo
DRUG: Dimebon

Sponsor

Medivation, Inc.

Collaborators

[object Object]